Author:
Hubatsch Ina,Ragnarsson Eva G E,Artursson Per
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology
Reference27 articles.
1. Artursson, P., Palm, K. & Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46, 27–43 (2001).
2. Stenberg, P., Norinder, U., Luthman, K. & Artursson, P. Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. 44, 1927–1937 (2001).
3. Artursson, P. & Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, 880–885 (1991).
4. Food and Drug Administration. FDA Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. (Food and Drug Administration, Baltimore, MD, 2000).
http://www.fda.gov/cder/guidance/3618fnl.htm
(2007).
5. Hubatsch, I., Lazorova, L., Vahlne, A. & Artursson, P. Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epithelium. Antimicrob. Agents Chemother. 49, 1087–1092 (2005).
Cited by
1122 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献